18th Jan 2024 The MOUNTAINEER study: a plain language summary looking at how effective and safe tucatinib plus trastuzumab is for treating people with metastatic colorectal cancer
17th Aug 2023 Plain Language Summary: looking at patients with EGFR exon 20 insertion-mutated non-small-cell lung cancer who received amivantamab in the CHRYSALIS study
21st Jun 2022 Darolutamide and survival in metastatic, hormone-sensitive prostate cancer: a plain language summary of the ARASENS trial